Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Alterations of the retinoblastoma gene in metastatic breast cancer.
Clin Exp Metastasis. 2011 Mar;28(3):319-26. doi: 10.1007/s10585-011-9375-y. Epub 2011 Jan 21.
Clin Exp Metastasis. 2011.
PMID: 21253829
Free PMC article.
Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers.
Berge EO, Knappskog S, Geisler S, Staalesen V, Pacal M, Børresen-Dale AL, Puntervoll P, Lillehaug JR, Lønning PE.
Berge EO, et al.
Mol Cancer. 2010 Jul 1;9:173. doi: 10.1186/1476-4598-9-173.
Mol Cancer. 2010.
PMID: 20594292
Free PMC article.
Item in Clipboard
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma.
Birkeland E, Busch C, Berge EO, Geisler J, Jönsson G, Lillehaug JR, Knappskog S, Lønning PE.
Birkeland E, et al. Among authors: berge eo.
Clin Exp Metastasis. 2013 Oct;30(7):867-76. doi: 10.1007/s10585-013-9587-4. Epub 2013 May 15.
Clin Exp Metastasis. 2013.
PMID: 23673558
Free PMC article.
Item in Clipboard
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Østenstad B, Lundgren S, Berge EO, Risberg T, Mjaaland I, Maehle L, Engebretsen LF, Lillehaug JR, Lønning PE.
Chrisanthar R, et al. Among authors: berge eo.
PLoS One. 2008 Aug 26;3(8):e3062. doi: 10.1371/journal.pone.0003062.
PLoS One. 2008.
PMID: 18725978
Free PMC article.
Item in Clipboard
Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO, Huun J, Lillehaug JR, Lønning PE, Knappskog S.
Berge EO, et al.
Biochim Biophys Acta. 2013 Mar;1830(3):2790-7. doi: 10.1016/j.bbagen.2012.12.004.
Biochim Biophys Acta. 2013.
PMID: 23246812
Item in Clipboard
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.
Knappskog S, Berge EO, Chrisanthar R, Geisler S, Staalesen V, Leirvaag B, Yndestad S, de Faveri E, Karlsen BO, Wedge DC, Akslen LA, Lilleng PK, Løkkevik E, Lundgren S, Østenstad B, Risberg T, Mjaaland I, Aas T, Lønning PE.
Knappskog S, et al. Among authors: berge eo.
Mol Oncol. 2015 Oct;9(8):1553-64. doi: 10.1016/j.molonc.2015.04.008. Epub 2015 May 8.
Mol Oncol. 2015.
PMID: 26004085
Free PMC article.
Item in Clipboard
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity.
Berge EO, Staalesen V, Straume AH, Lillehaug JR, Lønning PE.
Berge EO, et al.
Biochim Biophys Acta. 2010 Mar;1803(3):386-95. doi: 10.1016/j.bbamcr.2010.01.005. Epub 2010 Jan 15.
Biochim Biophys Acta. 2010.
PMID: 20080130
Free article.
Item in Clipboard
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.
Lønning PE, Berge EO, Bjørnslett M, Minsaas L, Chrisanthar R, Høberg-Vetti H, Dulary C, Busato F, Bjørneklett S, Eriksen C, Kopperud R, Axcrona U, Davidson B, Bjørge L, Evans G, Howell A, Salvesen HB, Janszky I, Hveem K, Romundstad PR, Vatten LJ, Tost J, Dørum A, Knappskog S.
Lønning PE, et al. Among authors: berge eo.
Ann Intern Med. 2018 Mar 6;168(5):326-334. doi: 10.7326/M17-0101. Epub 2018 Jan 16.
Ann Intern Med. 2018.
PMID: 29335712
Item in Clipboard
Cite
Cite